Physician profile
Laura E Graci
NPI 1912327560
$1,500.10
in general payments reported to CMS, 2019-2025
20 companies · $679 in 2025
The $679 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2024: $461 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.16 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $206.26 | 2024 | Veozah |
| Therapeuticsmd, INC. | $144.17 | 2021 | |
| Novo Nordisk INC | $140.61 | 2024-2025 | Wegovy |
| Amgen INC. | $125.40 | 2021-2025 | Evenity, Prolia, Prolia |
| Biohaven Pharmaceuticals, INC. | $124.31 | 2021 | |
| Mayne Pharma Commercial LLC | $113.65 | 2024-2025 | |
| Shield Therapeutics INC | $103.97 | 2024-2025 | |
| Biogen, INC. | $100.18 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $94.02 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $89.02 | 2025 | Myfembree |
| Lilly USA, LLC | $39.73 | 2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $38.44 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $35.28 | 2025 | Nexplanon |
| Exact Sciences Corporation | $32.08 | 2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $24.48 | 2024 | Injectafer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $23.66 | 2024 | Aptima |
| Pfizer INC. | $19.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.77 | 2024 | |
| Glaxosmithkline, LLC. | $15.47 | 2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $14.60 | 2025 | Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Graci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.